WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: DECEMBER ISSUE PUBLISHED

    DECEMBER 2024 Issue has been successfully launched on DECEMBER 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR December 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

EPIDEMIOLOGICAL CHARACTERISTICS OF TUBERCULOSIS IN IRAQ, MOSUL CITY AFTER ISIS INVASION

Dr. Farah Ghalib Al-Sultan*, Dr. Mohammed Assi Jasim, Dr. Jeehan Shaker Hassan, Dr. Bashar Hashim Abbass and Raghad Ghalib Alsultan

ABSTRACT

Background: leading to the destruction of health system infrastructure including the national tuberculosis program (NTP). Mosul city is one of the largest cities in Iraq. Which was badly invaded by ISIS (2014-2017), And since Tuberculosis (TB) is one of the major communicable diseases worldwide and one of the leading causes of death from a single infectious agent. So, this study was established to estimate TB prevalence and to describe the epidemiological profile and treatment outcomes of TB in Mosul city after the ISIS invasion. Methods: a descriptive retrospective study of drug-susceptible TB patients in the National Tuberculosis Program Center(NTP) of Ninawa. The Recording data were reviewed during 2018patient’s demographic, clinical, and laboratory characteristics were analyzed and treatment outcomes were -2021. Information on the determined. Results: A total of 840 tuberculosis patients were recorded. the incidence rate per 100,000 population in Mosul city was 10.8, 13.8, 11.1 and, 10.3 for the years 2018,2019, 2020 The age group 15–34 years were most affected with a percentage of 37%. The female patients were and 2021, respectively. predominant. The treatment outcomes for the study period were as follows: treatment success of about 95%, 1.7. Conclusion: % death rate,2.3%lost to fo The incidence of TB is within the Acceptable rate during the study period. the most commonly llow-up, with zero treatment failure rate. affected age group was 15-34, with satisfactory treatment outcomes. The female incidence rate was predominanmobilizing support to eliminate underlying risk factors and assure gendert, with a high percentage of extrapulmonary tuberculosis (EXTB). So, we recommended -equitable access, including gender sensitive services for TB prevention, diagnosis, treatment, care and support.

[Full Text Article] [Download Certificate]